What is Decently?
Decently operates as a medtech company and platform provider, with a specific focus on addressing brain trauma. Based in Manchester, England, the company leverages its technological platform to offer solutions within the medical technology sector. The recent major strategic investment signals a pivotal moment for Decently, indicating a strong market belief in its innovative approach to brain trauma care and its potential for broader application.
How much funding has Decently raised?
Decently has raised a total of $613K across 1 funding round:
Other Financing Round
$613K
Other Financing Round (2023): $613K with participation from Praetura Ventures, Bruntwood, and SFC Capital
Key Investors in Decently
Praetura Ventures
Praetura Ventures, now part of PXN Ventures, is dedicated to supporting entrepreneurs through comprehensive investment and operational guidance, particularly in Northern England, Northern Ireland, and Scotland. They focus on building stronger businesses by providing expertise beyond just capital.
Bruntwood
Bruntwood is a Manchester-based, family-owned property company that provides a range of commercial spaces including offices and retail units.
SFC Capital
SFC Capital is recognized as the UK's most active seed investor, combining an angel syndicate with its own funds to invest in SEIS and EIS-qualifying businesses across diverse sectors.
What's next for Decently?
The recent major strategic investment positions Decently for accelerated growth and expanded market reach. This capital will likely fuel further development of its platform, enhance its operational capabilities, and potentially drive strategic partnerships within the medtech industry. The company's focus on brain trauma suggests a trajectory aimed at making significant clinical and commercial impacts, supported by this latest round of financing.
See full Decently company page
